Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur | Dentistry Award | Excellence in Research

Prof Dr. Carmen Lefaucheur, Hopital Saint Louis, France

Prof. Dr. Carmen Lefaucheur is a highly accomplished nephrologist and expert in kidney transplantation. She serves as the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital, Paris, and is a Professor of Nephrology at Université Paris Cité. Additionally, she is the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR) and has an extensive background in personalized medicine for chronic diseases and organ transplantation. She holds multiple prestigious positions in international scientific committees and has received numerous awards, including the Paul I. Terasaki Clinical Science Award.

 

Publication profile

Orcid


Research Leadership
:

Dr. Lefaucheur is the Head of the Department of Nephrology and Kidney Transplantation at Saint-Louis Hospital and the Medical Director of the Paris Institute for Transplantation & Organ Regeneration (PITOR). Her leadership in these roles highlights her impact in advancing research and clinical practice in nephrology and transplantation.

Research Excellence:

She has received numerous prestigious awards, including the Paul I. Terasaki Clinical Science Award and the European Society of Organ Transplantation Award, recognizing her contributions to the field. Her research publications are highly cited, with significant papers in top-tier journals such as Nature Medicine.

Grant Leadership:

Dr. Lefaucheur coordinates major research grants, including the RO1 Grant for biomarkers and digital pathology, indicating her pivotal role in funding and leading cutting-edge research.

International Influence:

Her extensive involvement with international committees and scientific societies, such as the European Society of Organ Transplantation (ESOT) and the American Society of Transplantation (AST), demonstrates her influence and recognition in the global research community.

Educational Contributions:

Her roles in organizing scientific meetings and her invitations to speak at major international congresses further underline her leadership and expertise.

Publication Top Notes

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation

Conclusion

Dr. Lefaucheur embodies the qualities of excellence in research and would be a strong candidate for this award.

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus